481-490 of 1062 results
Impact of COVID-19 on derivatives
COVID-19 will have a range of impacts on over-the-counter derivative transactions. We set out below some key documentation issues arising as a consequence of COVID-19 and our practical tips. ...
Nucleus corporate law developments: rapid legal and regulatory responses to COVID-19; ASIC consults on pre-IPO relief for voluntary escrow and pre-disclosure communications; ACCC outlines enforcement priorities for 2020; and other corporate law developments
Rapid legal and regulatory responses to COVID-19; ASIC consults on pre-IPO relief for voluntary escrow and pre-disclosure communications; ASX compliance update; FIRB flags potential fee refunds for COVID-19 application withdrawals; and ACCC outlines enforcement priorities for 2020 and permits coordination to respond to COVID-19. ...
Takeover response in a COVID-19 environment: it's about being prepared
COVID-19 continues to impact ASX-listed entities across all sectors. Among others, market volatility and uncertain business conditions have made M&A challenging in the immediate term. ...
Allens advises Wesfarmers on ESG-incentivised $400m loan
The debt facility is linked to Wesfarmers' progress on two internal Environmental and Social Governance ( ESG ) targets – to reduce carbon emissions in its chemical operations and ambitious targets ...
Impact of COVID-19 on investment funds
As the COVID-19 pandemic creates turbulence in global financial markets and propels investors into a race for liquidity, we are beginning to see investment funds grappling with some of the issues they had confronted in 2007–2009 during the global financial crisis (the GFC). ...
Continuous disclosure during COVID-19: shining the spotlight on earnings and debt
In its latest compliance update, ASX reiterated that entities in financial difficulty (including with respect to their debt arrangements) will receive no special treatment. On earnings guidance, it was acknowledged that many listed entities have taken the opportunity to withdraw guidance issued before the outbreak of COVID-19. ASX also strongly encouraged entities to review their published guidance in light of COVID-19 and to either update it if it was not current or withdraw it in this highly uncertain climate. ...
Allens advises on sale of ASX-listed veterinary services business
VetPartners is a Sydney-based owner and operator of more than 140 veterinary clinics in Australia, New Zealand and Singapore. The acquisition of more than 100 NVC veterinary clinics will increase ...
Consumer Data Right Rules – what do the changes mean for you?
As part of the CDR rollout, as of 6 February 2020 the Big 4 banks are now required to disclose certain types of product data following a request, with the first types of consumer data to be shared from 1 July 2020. ...
Nucleus corporate law developments: ASIC to sample whistleblower policies; indexation of FIRB screening thresholds; Vodafone/TPG merger cleared in Federal Court; ACCC to commence home loan pricing inquiry; and other corporate law developments
Nucleus corporate law developments: ASIC to sample whistleblower policies; indexation of FIRB screening thresholds; Vodafone/TPG merger cleared in Federal Court; ACCC to commence home loan pricing inquiry; and other corporate law developments ...
COVID-19 and continuous disclosure: how you get ready
It is critical that listed entities understand how COVID-19 is likely to impact their businesses and are prepared to make necessary disclosures to the ASX. To date, the majority of ASX-listed entities have not made any disclosure in relation to COVID-19. In this update we have set out a number of scenarios that should be considered by listed clients as part of the proper and ongoing assessment of the need for disclosure under the ASX Listing Rules. ...